Constant Therapeutics initiates phase II study of TXA-27 in patients with COVID-19 in Israel Feb. 25, 2021
Carragelose lozenges show promising activity against respiratory viruses including SARS-CoV-2 Feb. 25, 2021
Janssen opens phase III study of rilematovir in neonates, infants and children with RSV infection Feb. 25, 2021
Inovio initiates dosing in phase Ib study of INO-4500 vaccine against Lassa Fever in West Africa Feb. 24, 2021
Novel COVID-19 MATE program candidate effectively neutralizes multiple strains of SARS-CoV-2 Feb. 24, 2021
Amyris announces promising preclinical data for its novel COVID-19 RNA vaccine platform Feb. 24, 2021
FDA grants clearance to proceed with clinical testing of tempol as treatment of COVID-19 Feb. 23, 2021
RSS